UGT2B4 and neoplasm: (Figure 5C) Functional enrichment analysis reveals that UGT2B4 co-expression genes enriched in tumor metabolic pathways such as 'de novo' IMP biosynthetic process, glutamine and monocarboxylic acid metabolic (Figure 5D).